Quality management

Integrate instruments without losing raw data and context

By NextEdge LabsUpdated 7 min read

For Laboratory IT and QC data-integrity leads · Plan implementation

TL;DR — what you’ll learn

  • Define the meaning, identity, unit and review state of each transferred value before connecting an instrument to LIMS.
  • Preserve access to original electronic records and relevant metadata; a final number is only part of the evidence.
  • Distinguish a duplicate transmission from a new result or authorised revision.
  • Test reconciliation, corrections and recovery so interface success means complete, correctly interpreted data.

A transferred number can still be an incomplete record

An instrument sends a result to the laboratory information management system, or LIMS. The number matches the screen, so the integration is accepted. Later, a reviewer cannot identify the preparation, unit, processing version or source record behind it. Manual transcription has been removed, but the evidence has become harder to interpret.

Pharma LIMS instrument integration needs a data contract, not just a connection. The contract defines what the instrument sends, what LIMS accepts, where the original record remains and how reviewers follow the evidence across systems. It also defines what happens when the message is incomplete, repeated or corrected.

FDA's US drug data-integrity guidance explains that static output may not preserve all information needed from a dynamic electronic record. Apply that principle to the actual instrument and intended use rather than assuming every printed result or exported file is a complete substitute. FDA data-integrity guidance.

Agree which system owns each part of the evidence

An instrument platform may retain raw acquisition data and processing history, while LIMS manages sample assignment, reviewed results and reporting. That division can work if the identifiers, access and retention arrangements are clear. Copying everything into LIMS is not automatically necessary, but losing the connection to required source data is not acceptable.

Document the authoritative source for acquisition, calculation, review and final reporting. If a calculation occurs in middleware, that component becomes part of the relevant workflow and needs its own controlled requirements and evidence. Do not treat it as an invisible pipe simply because users do not see a screen.

Confirm that reviewers can access source records for the required retention period, including after instrument software upgrades or retirement. A link that works only on the analyst's workstation does not provide dependable long-term access.

Define a data contract that rejects ambiguity

The contract should identify mandatory fields, permitted values, units, precision, timestamps and relationships. It should describe the meaning of status values and the difference between acquisition, processing and approval events. Map each source field explicitly rather than relying on similar labels.

Scroll horizontally to see all columns.

Define a data contract that rejects ambiguity
Contract fieldFailure it helps prevent
Sample and preparation identifiersResult attached to the wrong analytical work
Test and method versionResult interpreted against an unrelated requirement
Value, unit and precisionIncorrect conversion or rounding
Source record identifierInability to retrieve original evidence
Event and revision identifiersDuplicate or overwritten results
Review stateUnreviewed output presented as approved
Timestamp and time basisIncorrect event ordering

Use a defined rejection or quarantine path for incomplete messages. A missing unit should not be filled with the most common unit unless the approved contract explicitly establishes that meaning and the source conditions support it. Otherwise, a technically valid number can become a scientifically wrong record.

Worked example of replay and revision

Consider an illustrative instrument result identified as R-27, revision 1, for preparation P-14. The instrument sends a value of 10.2 milligrams per litre. LIMS stores the result and acknowledges receipt, but the acknowledgement is lost. The instrument sends the same message again.

The second transmission is a replay of the same event. The interface should recognise its stable identifier and avoid creating a second independent result. It should still record enough processing information to explain the retry and confirm the existing outcome.

Later, an authorised review produces revision 2 with a corrected result of 10.4 milligrams per litre and a documented reason. That event is not a duplicate of revision 1. The interface should preserve the relationship, retain the earlier record and route the revision through the defined review process.

Now suppose revision 2 arrives before a delayed copy of revision 1. Event ordering should follow the source identity and revision rules, not simply the order in which messages reached LIMS. The old replay must not restore the earlier result as the current approved value.

The reviewer needs to see what changed, why it changed and which report or decision used each version. The integration is successful only when these meanings remain intact, not merely when both numbers appear somewhere in a database.

Reconcile at several levels

Count source events, accepted messages, rejected messages and unresolved transfers. Then reconcile the actual analytical relationships. Matching totals can conceal a result attached to the wrong sample, so identity and key-field checks matter alongside counts.

Use a queue for exceptions with the source reference, reason, owner and permitted recovery action. A support analyst may repair a transport problem, but should not make a scientific result correction through an undocumented database edit. Define the boundary between technical recovery and laboratory record correction.

The LIMS sample-workflow guide explains how accepted evidence feeds testing and review states. The integration should not advance the entire sample to complete when only one required test has arrived.

Preserve numerical meaning

Unit conversion, decimal precision and rounding can materially change interpretation. Define where each calculation occurs and which value is retained for review. Display formatting should not alter the underlying result silently.

Test values at relevant boundaries using the approved requirements. Include a value that requires conversion, one with more precision than the report displays and one that cannot be represented by the expected format. The correct behaviour may be to reject or route an exception rather than truncate the data.

Non-numeric results need explicit handling too. Qualitative observations, censored values and method-specific result expressions should not be coerced into zero or a blank. The laboratory must define their meaning and how the receiving system represents them.

Design for outages and recovery

Specify where messages wait during a network outage, how long they are retained and how delivery is reconciled afterwards. The instrument's local storage and the integration queue should be assessed together. An automatic retry is useful only if it preserves identity and does not create duplicates.

After recovery, verify completeness before declaring the interface healthy. A green connection indicator can mean the service is reachable while several earlier results remain undelivered. Show the age and count of unresolved events, with escalation appropriate to their impact.

If a manual fallback is authorised, identify how manually entered records are distinguished and reconciled with later electronic messages. Otherwise, restored integration can create a second result for work already entered during the outage.

Test review and reporting as well as transport

Ask a reviewer to move from the LIMS result to its source record, relevant processing history and approval evidence. Test the same path with a corrected result and an archived instrument record. Access should work for the intended role without relying on shared credentials.

The audit-trail review guide covers the review process for relevant changes. The certificate-of-analysis verification guide explains why the final reported value still needs the correct product, lot and specification context.

Include exports and downstream reports in acceptance testing. A result may be represented correctly in LIMS but lose its unit or amendment status in the report sent to another system. Follow the evidence through the actual decision path rather than stopping at the interface endpoint.

Start with one instrument family

Select a representative workflow with stable sample identifiers and clearly understood source records. Build the contract with laboratory users, instrument specialists, IT and quality reviewers. Record unsupported cases instead of assuming one interface pattern will suit every instrument.

NextEdge Labs can implement the transfer, reconciliation and exception handling around that contract. A useful pilot demonstrates duplicate protection, revision handling, complete recovery and reviewer access to source evidence before adding more instrument types.

Summary and next actions

Instrument integration should preserve analytical meaning and evidence across systems. Reliable transport is necessary, but identity, units, revisions, source access and review state determine whether the result remains usable.

  • Define the authoritative systems and required data fields for one instrument workflow.
  • Test duplicate delivery, an authorised correction and messages arriving out of order.
  • Reconcile source events to accepted records and assign owners to unresolved transfers.
  • Verify the review and reporting path, including access to retained source data after recovery or upgrade.

Scope this automation around your operation

Tell us your current systems, transaction volume and the exception you need to resolve. We can discuss a focused first release, its review controls and how to measure the result.

START A CONVERSATION

Let’s talk about your next build.

Prepare your brief below, then review and send it in your email app to sales@nextlabsonline.com.

SELECTED INDUSTRYPharma & life sciences

Article: Integrate instruments without losing raw data and context

THE FIRST CONVERSATION

Your product idea, AI opportunity or automation challenge—and a useful first milestone.

All fields are required.

A few sentences about the problem, your users and timing are enough.

We’ll use your details to respond to your enquiry. Please don’t include patient records, passwords or confidential information. Privacy Policy · Website Terms.

About this guide

NextEdge Labs develops software, integrations and AI-assisted workflows. This guide presents practical workflow analysis with linked source references. Worked examples are illustrative, not client results.

Apply the sources within their stated market and scope, together with your approved procedures and the decisions of the responsible specialists.

Browse all Pharma & life sciences guides or explore our engineering capabilities.